Fundraising FoxPirche
1 known investors
Find your way into Pirche
Sign up to see every warm intro you have to Pirche
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pirche team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PIRCHE develops immunogenicity prediction tools for transplant medicine, using HLA epitope analysis to predict how a recipient's immune system will respond to a donor organ or cells. Its TxPredictor platform serves clinicians and laboratories across solid organ, stem cell, and allogeneic cell therapy settings for risk stratification, donor selection, and guiding immunosuppression.
Investors · 1
Frequently asked questions
- What does Pirche do?
- PIRCHE develops immunogenicity prediction tools for transplant medicine, using HLA epitope analysis to predict how a recipient's immune system will respond to a donor organ or cells. Its TxPredictor platform serves clinicians and laboratories across solid organ, stem cell, and allogeneic cell therapy settings for risk stratification, donor selection, and guiding immunosuppression.
- Who are Pirche's investors?
- Pirche's investors include Invesdor.